These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 35996810

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry.
    Pombo-Suarez M, Sanchez-Piedra C, Garcia-Magallón B, Pérez-Gómez A, Manrique-Arija S, Martín-Doménech R, Colazo M, Campos C, Campos J, Del Pino-Montes J, Arteaga MJ, Cea-Calvo L, Díaz-González F, Gómez-Reino JJ.
    Clin Rheumatol; 2021 Oct; 40(10):3979-3988. PubMed ID: 33907904
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
    Iannone F, Santo L, Anelli MG, Bucci R, Semeraro A, Quarta L, D'Onofrio F, Marsico A, Carlino G, Casilli O, Cacciapaglia F, Zuccaro C, Falappone PC, Cantatore FP, Muratore M, Lapadula G.
    Semin Arthritis Rheum; 2017 Aug; 47(1):108-114. PubMed ID: 28216195
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA.
    Iannone F, Favalli EG, Caporali R, D'Angelo S, Cantatore FP, Sarzi-Puttini P, Foti R, Conti F, Carletto A, Gremese E, Cauli A, Ramonda R, Palermo A, Epis O, Priora M, Bergossi F, Frediani B, Salaffi F, Lopalco G, Cacciapaglia F, Marchesoni A, Biggioggiero M, Bugatti S, Balduzzi S, Carriero A, Corrado A, Bongiovanni S, Benenati A, Miranda F, Fracassi E, Perra D, Ferraccioli G, Lapadula G.
    Joint Bone Spine; 2021 Jan; 88(1):105062. PubMed ID: 32755721
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-Term Retention Rate of Golimumab in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis in a Real-Life Setting.
    Serrano-Benavente B, Valor L, Del Río Blasco T, Janta I, González Benítez R, Nieto-González JC, Martínez-Barrio J, Ovalles Bonilla JG, Ariza A, López-Longo FJ, Álvaro-Gracia JM, Monteagudo I, González-Fernández CM.
    J Clin Rheumatol; 2022 Jan 01; 28(1):e150-e155. PubMed ID: 33492028
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study.
    Alegre-Sancho JJ, Juanola X, Rodríguez-Heredia JM, Manero J, Villa-Blanco I, Laiz A, Arteaga MJ, Cea-Calvo L, González CM.
    Medicine (Baltimore); 2021 Apr 02; 100(13):e25223. PubMed ID: 33787605
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective Analysis.
    Favalli EG, Selmi C, Becciolini A, Biggioggero M, Ariani A, Santilli D, Fusaro E, Parisi S, Massarotti M, Marchesoni A, Meroni PL.
    Arthritis Care Res (Hoboken); 2017 Jun 02; 69(6):867-874. PubMed ID: 27696735
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis.
    Lauper K, Courvoisier DS, Chevallier P, Finckh A, Gabay C.
    Arthritis Care Res (Hoboken); 2018 Dec 02; 70(12):1756-1763. PubMed ID: 29609199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.